Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.87NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.87NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.87NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.33NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.46NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.46NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.46NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.58 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.58 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.58 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.26NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.26NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.15NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.31NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.31NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CP.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CP.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CP.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBGNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBGNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBGNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.98 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.98 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.98 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.32NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-17471.2Singapore
BA.2.32NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.1.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.1.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EF.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EF.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EF.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XPNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XPNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XPNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DN.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DN.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used